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Background: Blood–brain barrier (BBB) disruption is an integral feature of numerous neurological disorders. However,
there is a relative lack of knowledge regarding the underlying molecular mechanisms of immune-mediated BBB
disruption. We have previously shown that CD8 T cells and perforin play critical roles in initiating altered permeability of
the BBB in the peptide-induced fatal syndrome (PIFS) model developed by our laboratory. Additionally, despite having
indistinguishable CD8 T cell responses, C57BL/6J (B6) mice are highly susceptible to PIFS, exhibiting functional motor
deficits, increased astrocyte activation, and severe CNS vascular permeability, while 129S1/SvImJ (129S1) mice remain
resistant. Therefore, to investigate the potential role of genetic factors, we performed a comprehensive genetic analysis
of (B6 x 129S1) F2 progeny to define quantitative trait loci (QTL) linked to the phenotypic characteristics stated above
that mediate CD8 T cell-initiated BBB disruption.
Results: Using single nucleotide polymorphism (SNP) markers and a 95% confidence interval, we identified one QTL
(PIFS1) on chromosome 12 linked to deficits in motor function (SNP markers rs6292954, rs13481303, rs3655057, and
rs13481324, LOD score = 3.3). In addition we identified a second QTL (PIFS2) on chromosome 17 linked to changes in
CNS vascular permeability (SNP markers rs6196216 and rs3672065, LOD score = 3.7).
Conclusions: The QTL critical intervals discovered have allowed for compilation of a list of candidate genes implicated
in regulating functional deficit and CNS vascular permeability. These genes encode for factors that may be potential
targets for therapeutic approaches to treat disorders characterized by CD8 T cell-mediated BBB disruption.
Keywords: Quantitative trait loci (QTL), Single nucleotide polymorphism (SNP), Blood–brain barrier (BBB), Theiler’s
murine encephalomyelitis virus (TMEV), Peptide-induced fatal syndrome (PIFS), CD8 T cell, CNS vascular permeabilityBackground
Disruption of the blood brain barrier (BBB) is a common
feature of several devastating immune-mediated neuro-
logical disorders, including multiple sclerosis, dengue
hemorrhagic fever, cerebral malaria, stroke, and acute
hemorrhagic leukoencephalitis (AHLE) [1-8]. The under-
lying molecular mechanisms of BBB disruption observed in
these conditions remain poorly understood, undermining* Correspondence: Johnson.Aaron2@mayo.edu
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reproduction in any medium, provided the orthe development of potential therapeutic approaches for
human diseases characterized by BBB disruption. Our lab
developed an inducible murine model of CNS vascular
permeability using a variation of the Theiler’s murine en-
cephalomyelitis virus (TMEV) model commonly used to
study multiple sclerosis. In this model, peptide-specific
stimulation of CNS-infiltrating CD8 T cells in vivo initi-
ates disruption of the BBB, resulting in astrocyte activa-
tion, severe CNS vascular permeability, and functional
motor deficits, followed by death within 48 hours. This
peptide induced fatal syndrome (PIFS) is dependent onl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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T cells, TNF-α, IFN-γ, LTβR or IL-1 [9,10].
In addition to CNS-infiltrating CD8 T cells and their
effector functions, there is potential for other genetic
factors to contribute to BBB disruption. C57BL/6J (B6)
and 129S1/SvImJ (129S1) mice both express the H2-Db
class I molecule and thus are resistant to chronic TMEV
infection and demyelinating syndrome [11-13]. However,
despite having identical MHC class I molecules, epitope-
specific CNS-infiltrating CD8 T cells, and equivalent
cytotoxic T lymphocyte (CTL) perforin-mediated killing,
B6 mice are highly susceptible to PIFS, whereas 129S1
mice remain resistant. This difference in susceptibility
was illustrated by higher glial fibrillary acidic protein
(GFAP) expression, increased CNS vascular permeability,
and severe functional motor deficit in VP2121-130-treated
B6 mice when compared to VP2121-130-treated 129S1
mice. Furthermore, this susceptibility is transferable
with the bone marrow compartment. 129S1 mice
reconstituted with B6 bone marrow exhibit severe CNS
vascular permeability, microhemorrhage formation, and
functional deficit when compared to 129S1 mice receiv-
ing autologous bone marrow transfer [14]. Through an
initial microsatellite analysis, we have determined that
the PIFS phenotype is not mediated through a single
gene, but rather is likely to be a complex condition [15].
In order to provide a more comprehensive analysis
and determine the location of genes that influence the
PIFS phenotypes, we analyzed the F2 generation of
brother-sister mated F1 animals from a B6 and 129S1
cross using QTL analysis. The quantifiable traits of
astrocyte activation via GFAP expression, CNS vascular
permeability via fluorescent molecule diffusion across
the BBB, and functional motor deficits measured with
rotarod activity were chosen for study because they dif-
fer by or exceed two standards of deviation when mea-
sured in the two parental strains, which is optimal for
QTL analysis [14,16]. We identified chromosomal re-
gions that harbored QTLs responsible for functional def-
icit and CNS vascular permeability. Additionally, we
have identified candidate genes implicated in regulating
these traits. These genes can be further investigated and
may become potential targets for therapeutic approaches
to ameliorate neurological disorders characterized by
BBB disruption.
Results
As shown in Figure 1A, B6 mice were crossed with
129S1 mice to yield an F1 generation, and then F1 hy-
brid mice were brother-sister mated to produce 303 F2
progeny. These mice were intracranially infected with
TMEV and then intravenously administered VP2121-130
peptide 7 days later to induce PIFS. Mice were then
analyzed for CNS vascular permeability, astrocyteexpression of GFAP, and functional motor deficit (see
Methods section). B6 mice were susceptible to each
of these phenotypes, while 129S1 mice remained resist-
ant [14]. F2 mice displayed variable susceptibility to
each of these traits and were divided into susceptible
and resistant groups based on whether they exhibited
the trait or not. CNS vascular permeability was evaluated
using a fluorescent plate reader to detect FITC-albumin
leakage in brain homogenates using established methods
[14,17,18]. Samples were read at A488, and a threshold
value of 500 was used to determine susceptibility or re-
sistance. Astrocyte expression of GFAP was detected
through Western blot analysis as previously published
[14,18]. Expression values were based on GFAP protein
levels normalized to GAPDH. We used a threshold value
of 50 to categorize F2 mice into susceptible and resistant
groups. Functional motor deficit was assessed using the
rotarod behavioral assay. A threshold value of 50% initial
motor ability was used to categorize mice as susceptible
or resistant (Additional file 1). The phenotype data for
each trait is illustrated by the mean ± SEM for the F2
susceptible group and the F2 resistant group (Figure 1B).
No significant sex differences were observed in the F2
mice (data not shown).
Identification of QTL controlling quantitative traits
associated with PIFS
Of the 671 SNPs analyzed, the most significant linkage
to susceptibility to PIFS was observed with markers on
chromosomes 12 and 17, as illustrated by log-likelihood
plots (Figure 2). Significant LOD scores were obtained
for functional motor deficits, which mapped to chromo-
some 12 (LOD = 3.3) (Figure 2A), and CNS vascular per-
meability, which mapped to chromosome 17 (LOD = 3.7)
(Figure 2B). No significant LOD score was obtained for
astrocyte activation as measured by GFAP expression
(Figure 2C). Parental allele distribution of the linked
SNPs within the QTL intervals that mapped to the phe-
notypes of functional motor deficits and CNS vascular
permeability were detected using 2 × 3 contingency ta-
bles comparing B6 homozygous (BB), heterozygous (BS),
and 129S1 homozygous (SS) mice. The QTL location on
chromosome 12 (PIFS1, LOD 3.3), estimated by a 95%
confidence interval, was from 4.7 cM to 10.1 cM, with
the peak of linkage at 6.0 cM. The QTL location on
chromosome 17 (PIFS2, LOD 3.7), also estimated by a
95% confidence interval, was from 5.7 cM to 12.5 cM,
with the peak of linkage at 10.8 cM. We found that the
129S1 strain contributed to low rotarod performance,
while the B6 strain contributed to high rotarod perform-
ance on these markers (Table 1A). In addition, the
129S1 strain contributed to increased CNS vascular per-
meability, whereas the B6 strain contributed to reduced
CNS vascular permeability in the PIFS model (Table 1B).
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Figure 1 Approach to map QTL for functional motor deficits, CNS vascular permeability, and astrocyte activation. (A) PIFS-susceptible B6
mice were crossed with PIFS-resistant 129S1 mice to yield an F1 generation which was previously determined to be resistant to PIFS. F1 hybrid
mice were then brother-sister mated to produce 303 F2 progeny with variable susceptibility to traits associated with PIFS, including functional
motor deficits, astrocyte GFAP expression, and CNS vascular permeability measured by FITC-albumin leakage. DNA from 273 randomly selected F2
progeny were analyzed using Illumina Chip Technologies. SNPs with a known cM value were analyzed for the relationship between quantifiable
traits (functional motor deficits, CNS vascular permeability, and astrocyte expression of GFAP) and genotype. (B) F2 mice displayed variable
susceptibility to each of the traits associated with PIFS and were divided into susceptible and resistant groups based on whether they exhibited
the trait or not. CNS vascular permeability was evaluated using a fluorescent plate reader to detect FITC-albumin leakage in brain homogenates.
Samples were read at A488, and a threshold value of 500 was used to determine susceptibility or resistance. Astrocyte expression of GFAP was
detected through Western blot analysis. Expression values were based on GFAP protein levels normalized to GAPDH. We used a threshold value
of 50 to categorize F2 mice into susceptible and resistant groups. Functional motor deficit was assessed using the rotarod behavioral assay. A
threshold value of 50% initial motor ability was used to categorize mice as susceptible or resistant. All values are displayed as mean ± SEM.





Figure 2 QTL analysis of functional motor deficits, CNS vascular permeability, and astrocyte activation. Log-likelihood plots of (A)
functional motor deficits as measured by rotarod performance, (B) CNS vascular permeability as measured by leakage of FITC-albumin into the
CNS, and (C) astrocyte activation as measured by GFAP expression. The upper graph charts the data as a LOD score. The solid black line depicts
the significance threshold. The lower graph depicts the estimated QTL effects. Significant LOD scores were obtained for (A) functional motor
deficits, which is shown to map to chromosome 12 (LOD = 3.3), and (B) CNS vascular permeability, which is shown to map to chromosome
17 (LOD = 3.7).
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Table 1 Chi-square analysis of functional deficit and CNS vascular permeability
A. SNP Low F2s (n = 145) High F2s (n = 128) Chi-square test Chi-square p-value LOD score
BB BS SS BB BS SS
rs6292954 18 80 47 50 51 27 25.93 0.000002 3.65
rs13481303 17 83 45 46 56 26 22.71 0.000012 3.66
rs3655057 19 80 46 46 54 28 19.66 0.000054 3.30
rs13481324 21 79 45 49 52 27 20.28 0.000039 3.35
B. SNP Low F2s (n = 182) High F2s (n = 91) Chi-square test Chi-square p-value LOD Score
BB BS SS BB BS SS
rs6196216 58 88 36 20 39 32 8.24 0.016245 3.73
rs3672065 60 85 37 19 39 33 9.27 0.009706 3.79
2 × 3 contingency tables comparing B6 homozygous (BB), heterozygous (BS), and 129S1 homozygous (SS) mice with regards to (A) functional motor deficits as
measured by rotarod performance and (B) CNS vascular permeability as measured by leakage of FITC-albumin into the CNS. (A) Mice displaying <50% initial ability
were placed in the low F2 group, while mice displaying >50% initial ability were placed in the high F2 group. 129S1 contributes to low rotarod performance on
chromosome 12 markers rs6292954, rs13481303, rs3655057, and rs13481324, while B6 contributes to high rotarod performance on these markers. (B) The low F2
group consists of mice with FITC scores <500, while the high F2 group consists of mice with FITC scores >500. B6 contributes to less CNS vascular permeability on
chromosome 17 markers rs6196216 and rs3672065, while 129S1 contributes to more CNS vascular permeability on these markers.
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functional deficit and CNS vascular permeability in CD8 T
cell-initiated BBB disruption
Using the Mouse Genome Informatics Database resources
(www.informatics.jax.org), we performed a search between
the base pairs of the significant loci found on chromosome
12 (SNP markers rs6292954, rs13481303, rs3655057, and
rs13481324) and chromosome 17 (SNP markers rs6196216
and rs3672065) in order to discover genes located in prox-
imity with these loci. Our search revealed 34 candidate
genes on chromosome 12 and 58 candidate genes on
chromosome 17 (Table 2). We then prioritized these genes
based on known or presumed biological function and pre-
vious studies, allowing us to narrow down this list to 6
genes of interest on chromosome 12 and 8 genes of inter-
est on chromosome 17. We focused on genes exhibiting
potential immunological, hematopoietic, apoptotic, or
CNS-related functions since factors related to these pro-
cesses are likely to play a role in CD8 T cell-initiated BBB
disruption. We then used the Mouse Phenome Database
(www.phenome.jax.org) to determine the number of SNPs
in these genes of interest that are different between the B6
and 129S1 mouse strains as well as the location of these
SNPs (Table 3).
Discussion
In this study, we investigated the role of genetic factors
involved with CD8 T cell-initiated fatal BBB disruption.
We previously demonstrated that despite having identi-
cal MHC class I molecules, epitope-specific CNS-
infiltrating CD8 T cells, and similar levels of perforin-
mediated killing, the B6 strain is highly susceptible to
PIFS, while the 129S1 strain remains resistant [14,15].
This susceptibility is transferable with the bone marrow
compartment, as 129S1 mice reconstituted with B6 bone
marrow exhibit characteristics of the PIFS phenotype,which include severe CNS vascular permeability, mic-
rohemorrhage formation, and functional motor deficit,
when compared to 129S1 mice receiving autologous
bone marrow transfer [14]. Furthermore, by conducting
a backcross of (129S1 × B6) F1 mice, we determined
through microsatellite analysis that susceptibility to PIFS
is dictated in a complex fashion [15]. Therefore, we in-
vestigated the characteristics of PIFS in F2 generation
mice through analysis of three quantifiable traits, which
include functional motor deficit on rotarod, activation of
astrocytes, and CNS vascular permeability. Since we
have shown that the means of each of these traits mea-
sured between the B6 and 129S1 mouse strains differ by
greater than two standards of deviation, we expected to
find a set of QTLs for each trait measured [14].
We identified one novel QTL (PIFS1) on chromosome
12 linked to functional motor deficits and a second novel
QTL (PIFS2) on chromosome 17 linked to CNS vascular
permeability. While causality cannot be determined in this
study, we have not observed motor dysfunction without
CNS vascular permeability in the PIFS model. Further-
more, we discovered that the SNP markers identified
within the QTL intervals for the PIFS-resistant 129S1
strain actually contributed to low rotarod performance
and more CNS vascular permeability, while the B6 strain
contributed to functional motor preservation and reduced
CNS vascular permeability. While this was an unexpected
result, it is possible that the expression of susceptibility
loci may be suppressed by the presence of other loci in the
parental strain. However, since new genetic combinations
can be revealed through an F2 analysis, the identification
of cryptic QTL becomes possible. For example, a genetic
analysis of (B6 × FVB/NJ) F2 progeny to study atheroscler-
osis revealed that the FVB/NJ strain, which is more re-
sistant to atherosclerosis than the B6 strain, actually
contributed to high levels of the disease [19]. Therefore,
Table 2 Candidate genes implicated in regulating
functional deficit and CNS vascular permeability in fatal
BBB disruption
Gene Chr cM Genome coordinates
Nt5c1b 12 5.27 10376779-10396979 (+)
Rdh14 12 5.29 10397586-10402368 (+)
1700034J04Rik 12 5.58 11228267-11229010 (−)
4930511A02Rik 12 5.58 11445039-11451618 (+)
Gen1 12 5.58 11247732-11272593 (−)
Kcns3 12 5.58 11097008-11157648 (−)
Msgn1 12 5.58 11215188-11215754 (−)
Rad51ap2 12 5.58 11462885-11469734 (+)
Smc6 12 5.58 11272692-11326591 (+)
Vsnl1 12 5.58 11332053-11443455 (−)
Fam49a 12 5.63 12268945-12383165 (+)
Gm17337 12 6 12794791-12801091 (+)
4930519A11Rik 12 6.11 12909526-12914057 (+)
Mycn 12 6.14 12942902-12948720 (−)
Ddx1 12 6.4 13226113-13255980 (−)
Nbas 12 6.45 13275933-13590616 (+)
Fam84a 12 6.93 14154405-14158844 (−)
Gm16497 12 7.03 14268340-14292490 (+)
Trib2 12 7.3 15798533-15823683 (−)
Gm5432 12 7.28 15823809-15894961 (+)
Lpin1 12 7.9 16542475-16596576 (−)
Ntsr2 12 7.98 16660276-16667042 (+)
Greb1 12 8 16677421-16807692 (−)
2410004P03Rik 12 8.04 17011764-17018360 (−)
E2f6 12 8.04 16817771-16833549 (+)
Kcnf1 12 8.04 17178906-17183694 (−)
Pqlc3 12 8.04 16995454-17007214 (−)
Rock2 12 8.04 16901784-16995080 (+)
Atp6v1c2 12 8.06 17291527-17336165 (−)
Pdia6 12 8.06 17273351-17291576 (+)
Nol10 12 8.07 17355299-17436901 (+)
Mir3066 12 8.08 17362198-17362280 (+)
Gm19657 12 8.09 17436584-17441442 (−)
Odc1 12 8.11 17551679-17558308 (+)
Pde10a 17 4.96 8718237-9179513 (+)
1700010I14Rik 17 5.53 9181198-9201184 (+)
6530411M01Rik 17 5.97 9340584-9360701 (−)
Gm17728 17 7.33 9614925-9615323 (+)
Gm17748 17 7.33 9614805-9622259 (−)
Pabpc6 17 7.47 9859362-9862569 (−)
Qk 17 7.75 10399336-10512226 (−)
A230009B12Rik 17 7.8 10649082-10685921 (+)
Table 2 Candidate genes implicated in regulating
functional deficit and CNS vascular permeability in fatal
BBB disruption (Continued)
Gene Chr cM Genome Coordinates
Gm10513 17 7.8 11918744-11925211 (−)
Gm16168 17 7.8 10689312-10762262 (+)
Gm16169 17 7.8 11000700-11019491 (+)
Pacrg 17 7.8 10595878-11033177 (−)
Park2 17 7.8 11033250-12256227 (+)
Agpat4 17 8.33 12311570-12412511 (+)
Map3k4 17 8.42 12420487-12511526 (−)
4732491K20Rik 17 8.5 12511751-12520116 (+)
Plg 17 8.5 12571475-12612250 (+)
Slc22a3 17 8.52 12612838-12700570 (−)
C030013G03Rik 17 8.56 12659710-12672444 (+)
Slc22a2 17 8.61 12777055-12821331 (+)
Slc22a1 17 8.63 12841740-12868704 (−)
Igf2r 17 8.64 12875272-12962530 (−)
Airn 17 8.66 12934177-13052988 (+)
Gm19270 17 8.66 12926941-12946579 (+)
Gm17592 17 8.69 13030801-13031000 (−)
Mas1 17 8.69 13033945-13061009 (−)
Mrgprh 17 8.7 13068900-13070708 (+)
Pnldc1 17 8.71 13081768-13102866 (−)
Acat3 17 8.72 13116699-13133268 (−)
Mrpl18 17 8.72 13104215-13109211 (−)
Snora20 17 8.72 13115723-13115783 (+)
Tcp1 17 8.72 13108567-13117933 (+)
Acat2 17 8.73 13135756-13153613 (−)
Wtap 17 8.73 13159662-13185412 (−)
Sod2 17 8.75 13200705-13210985 (+)
Gpr31b 17 8.76 13244187-13245146 (−)
Tcp10b 17 8.76 13253970-13275347 (+)
Gm11166 17 8.78 13289526-13291338 (−)
Unc93a 17 8.78 13301483-13324657 (−)
Gm10512 17 8.81 13397908-13399077 (+)
Smok2a 17 8.82 13414054-13420524 (+)
Smok2b 17 8.82 13421718-13430055 (+)
Tcp10c 17 8.86 13547438-13570089 (+)
Rnu6 17 8.88 13624899-13625005 (−)
2700054A10Rik 17 8.9 13675419-13898832 (−)
Tcte2 17 8.9 13675419-13898832 (−)
Gm16050 17 8.91 13695065-13704059 (+)
Gm8603 17 8.91 13709618-13711010 (+)
Smok4a 17 8.91 13714322-13721299 (+)
4930488N24Rik 17 8.95 14238826-14243457 (−)
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Table 2 Candidate genes implicated in regulating
functional deficit and CNS vascular permeability in fatal
BBB disruption (Continued)
Dact2 17 8.95 14332238-14340838 (−)
Gm16046 17 8.95 13812667-13820523 (−)
Gm16049 17 8.95 13896413-13897375 (−)
Gm16052 17 8.95 13896377-13896992 (−)
Gm7168 17 8.95 14085380-14087685 (+)
Gm7356 17 8.95 14137246-14138709 (−)
Gm7358 17 8.95 14195012-14196538 (−)
Mllt4 17 8.95 13897546-14043157 (+)
Shown are a list of genes between the significant loci found on chromosome
12 (SNP markers rs6292954, rs13481303, rs3655057, and rs13481324) and
chromosome 17 (SNP markers rs6196216 and rs3672065). Genes that
exhibited potential immunological, hematopoietic, apoptotic, or
CNS-related functions were categorized as genes of interest.
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note that disease-resistant strains also harbor susceptibility
alleles, consistent with other genetic studies [19-21].
Identification of QTL regions that influence resistance
and susceptibility to PIFS has enabled us to identify candi-
date genes that mediate protection from PIFS and thus are
potential targets for therapy in diseases characterized by
BBB disruption. Genes whose biological function had rele-
vance to playing a role in BBB disruption were categorizedTable 3 Genes of interest potentially related to B6 and 129S1
disruption
Chromosome 12 (Rotarod) Proposed functi
Vsnl1 Neuronal Ca2+ sensor
Ddx1 Viral responses
Trib2 Induces apoptosis of cells in hem
CD8 T cells
Lpin1 Demyelination; actin cytoskelet
Kcnf1 Neurotransmitter release; neur
Rock2 Actin cytoskeleton organizatio
angiogenesis
Chromosome 17 (CNS vascular
permeability)
Proposed functi
Pde10a Signal transduction; neuron
Qk Myelinization; axon ensheathme
Pacrg Myelinization
Park2 Neuron projection; neu
Plg Apoptotic processes; vessel
Igf2r Edema
Mas1 Inflammatory respo
Mllt4 Adherens junctions; cell
Shown are the genes of interest found on chromosome 12 and chromosome 17 alo
(www.phenome.jax.org) was used to determine the number of SNPs that are differe
(Abbreviations: Cn nonsynonomous codon, Cs synonomous codon, U5 51 UTR varianas genes of interest and will be targeted first in future stud-
ies. Genes of interest pertaining to mouse functional ability
on chromosome 12 include tribbles homolog 2 (Trib2),
which has been shown to induce apoptosis of cells in
hematopoietic origin. Additionally, mice homozygous for a
null Trib2 allele display increased mean percentage of
CD8 T cells. Furthermore, Trib2 has also been character-
ized as one of the top non-HLA markers associated with
susceptibility to multiple sclerosis [22]. Considering our
previous research on the critical roles of CD8 T cells and
hematopoietic factors in mediating BBB disruption, Trib2
will be a candidate for future study [9,10,14,15,17,18].
Other genes of interest include Lpin1 and Rock2, which
both play a role in organization of the actin cytoskeleton,
Vsnl1, which plays a role in neuronal Ca2+ sensor proteins,
Kcnf1, which plays a role in neurotransmitter release and
neuronal excitability, and Ddx1, which plays a role in viral
responses. Genes of interest on chromosome 17 that may
affect CNS vascular permeability include Pde10a, Qk,
Pacrg, Park2, Plg, Igf2r, Mas1, and Mllt4. These genes ex-
hibit a variety of functions that may be involved in causing
disruption of the BBB and ensuing CNS vascular perme-
ability. For example, Mllt4 has been shown to play a role
in adherens junctions and cell junctions. Plg has been
demonstrated to be involved in apoptotic processes and
vessel development. Additionally, Mas1 is involved inphenotypic differences in CD8 T cell-initiated BBB
on # SNPs different between
strains
SNP locations
proteins 24 All I
2 All I
atopoietic origin; 40 1 Cs, 1 U5, 38 I
on reorganization 531 3 Cn, 8 Cs, 27 U3,
493 I
onal excitability 35 4 Cs, 7 U5, 24 U3
n; regulation of 330 1 Cn, 3 Cs, 5 U3,
321 I
on # SNPs different between
strains
SNP locations
al cell bodies 1268 Unspecified
nt; vasculogenesis 214 12 U3, 202 I
265 2 U5, 263 I
ron death 3198 2 Cs, 1 U3, 3195 I
development 38 1 Cn, 37 I
7 All I
nses 2 All I
junctions 7 All I
ng with their proposed functions. The Mouse Phenome Database
nt between the B6 and 129S1 mouse strains as well as their location.
t, U3 31 UTR variant, I intron-variant).
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Qk and Pacrg both play a role in myelinization. Further-
more, Park2 has been shown to contribute to neuron pro-
jection as well as neuron death, and Pde10a has been
shown to be involved in signal transduction and neuronal
cell bodies (www.informatics.jax.org/). Furthermore, we
used the Online Mendelian Inheritance in Man (OMIM)
database (http://omim.org/) to investigate whether any of
these genes of interest have been associated with any
human neurological diseases. We found that Vsnl1,
which is located on mouse chromosome 12, has been
implicated in Alzheimer’s disease. Qk, located on mouse
chromosome 17, has been proposed to play a role in
myelin and oligodendrocyte dysfunction in schizophre-
nia. Additionally, Pacrg, also located on mouse chromo-
some 17, may be involved in acquired, communicating
hydrocephalus (http://omim.org/).
Our comprehensive genetic analysis has allowed us to
create this list of candidate genes, which will serve as a
critical starting point in elucidating the underlying mo-
lecular mechanisms of BBB disruption in neurological
diseases. This will be an essential first step in developing
potential therapeutic approaches to treat these diseases.
Validating strain differences in primary DNA sequences
in candidate genes and performing bioassays to test for
functional consequences of primary DNA differences
will be essential in this process. It will also be essential
to test candidate genes for their ability to contribute to
susceptibility or resistance to functional deficit and BBB
disruption in the PIFS model. Testing specific congenic
strains in which potential genes of interest will be intro-
duced will help define the importance of the QTLs
detected in this study. This approach has been successful
in other genetic studies [23,24]. Generation of bacterial
artificial chromosome (BAC) transgenic mice using the
candidate genes we have identified will also be beneficial
in evaluating the importance of our novel QTLs. This
will enable us to test whether strain-specific variation in
one or more of these genes is responsible for causing the
QTL effects we observed [25]. This method has been
carried out successfully in other genetic studies of strain
comparison, such as evaluating the difference in seizure
susceptibility between B6 and DBA/2 mouse strains [25].
Ultimately, results obtained from these experiments may
hold promise for therapeutic intervention of immune-
mediated neurological diseases characterized by exten-
sive BBB disruption.
Conclusions
The comprehensive genetic analysis performed in this
study has enabled us to identify QTL linked to func-
tional motor deficits and CNS vascular permeability,
which are both devastating characteristics associated
with CD8 T cell-initiated BBB disruption. Furthermore,identification of these critical QTL intervals has revealed
a list of candidate genes implicated in regulating these
traits. These findings are important because they will set
the stage for future research to identify novel factors
encoded by these genes that affect immune-mediated
BBB disruption. This may ultimately hold promise for
devising potential therapeutic approaches to treat the
numerous immune-mediated neurological disorders
characterized by BBB disruption.
Methods
Animals
Male and female C57BL/6J (B6) (stock# 000664) and
129S1/SvImJ (129S1) (stock# 002448) mice were
obtained from Jackson laboratories (Bar Harbor, ME).
(B6 × 129S1) F1 hybrids were brother-sister mated to
produce (B6 × 129S1) × (B6 × 129S1) F2 progeny. All F1
and F2 mice were produced in the animal colony at the
University of Cincinnati (Cincinnati, OH). In order to
obtain large cohorts, mice were tested at 4–7 months of
age. All experiments were approved by the Institutional
Animal Care and Use Committee of the University of
Cincinnati and Mayo Clinic.
Induction of CNS vascular permeability using the PIFS
model
CNS vascular permeability was induced as previously de-
scribed [15,17,18]. Briefly, all mice were intracranially
infected with 2 × 106 PFU Daniel’s strain of TMEV. 7 days
post-TMEV infection, during the peak of CD8 T cell ex-
pansion, mice were intravenously administered 0.1 mg
VP2121-130 (FHAGSLLVFM) peptide [15].
Rotarod
In order to evaluate functional motor deficits, mice were
placed on the Rotamex-5 rotarod apparatus (Columbus
Instruments) increasing from 5–40 RPMs over 7 minutes.
Mice were trained twice daily for 3 consecutive days. The
motor performance of mice was then assessed the day fol-
lowing this training period in order to establish baseline
ability, which was considered the average of two trials.
Mice were then injected with VP2121-130 peptide to induce
CNS vascular permeability and their motor performance
was assessed again 24 hours later. Final scores were
depicted as percent initial motor ability (day 2 average/day
1 average × 100).
Fluorescein isothiocyanate (FITC)-albumin permeability assay
Mice were given an intravenous injection of 10 mg
FITC-albumin (Sigma #A9771) 23 hours post-VP2121-130
peptide administration to induce PIFS. Whole brains
were harvested one hour after administration of FITC-
albumin and frozen on dry ice. Brain tissue samples were
homogenized in radioimmunoprecipitation assay (RIPA)
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X-100, 1% Na deoxycholate, 0.1% SDS and protease in-
hibitor cocktail (Pierce #78410) pH 7.5] and spun for
15 min at 10,000 RPM. Protein concentration was
assessed using the BCA protein assay (Pierce #23223).
Samples were then normalized for protein content and
read on a fluorescent plate reader at 488 nm excitation
and 525 nm emission to detect FITC-albumin leakage
into the brain. Data was collected using SpectraMax
software (Molecular Devices).
Western blot for glial fibrillary acidic protein (GFAP)
detection
Normalized protein samples from the FITC-albumin per-
meability assay were also used for western blot analysis. In
order to detect GFAP, 10 ug of protein was loaded per well
on 4–20% precise protein gels (Pierce #25244) with BupH
Tris-HEPES-SDS running buffer (Pierce #28398). Tris
transfer buffer [400 mmol/mLTris base, 70 mmol/mL gly-
cine, 10% methanol] was used to transfer gels onto
Immun-Blot PVDF membranes (Biorad #162-0177). GFAP
was detected by staining with mouse anti-GFAP (1:1000
BD Pharmingen #556329) and goat anti-mouse IgG conju-
gated to horseradish peroxidase (Sigma #A3682). Scion
Image Software (Scion Corp) was used to analyze Western
blot films. Values were based on GFAP protein levels nor-
malized to GAPDH [14,18].
Quantitative trait linkage analysis
DNA from 273 F2 progeny (124 males; 149 females)
were analyzed on 2 SNP chips using Illumina Chip
Technologies. Two B6 and 2 129S1 mice were included
as controls. In order to map genes controlling suscepti-
bility to PIFS in the B6 × 129S1 F2 model, we
constructed a genetic linkage map of the mouse genome
by analyzing 273 randomly selected mice using Illumina
Chip Technologies. Of the 1449 analyzable SNPs, 874
were found to be unique between the two strains. 671 of
these SNPs had a known cM value and thus were ana-
lyzed for the relationship between quantifiable traits and
genotype [26]. Based on previous studies, we used func-
tional motor deficits measured by rotarod, CNS vascular
permeability measured by FITC-albumin leakage, and
astrocyte activation measured by GFAP expression as
quantifiable traits predictive of susceptibility to PIFS
[14,15]. Threshold values were generated using the
WinQTL Cartographer with 1,000 permutations of our
data set to correct for multiple testing [27]. Interval
mapping was used to identify significant linkage using a
critical value of p = 0.05 and a 95% confidence interval
(Additional file 2). A chi-square test statistic for each
SNP marker showing linkage within a QTL interval was
obtained using 2 × 3 contingency tables to demonstrate
the distribution of parental strain alleles within the F2population using the quantitative traits of functional
motor deficits, CNS vascular permeability, and astrocyte
activation. Since F2 mice displayed variable susceptibil-
ity, they were divided into two groups, low F2s and high
F2s, based on whether or not they exhibited functional
motor deficits or CNS vascular permeability. For func-
tional motor deficits, low F2s were defined as those mice
displaying <50% initial ability, while high F2s were de-
fined as mice displaying >50% initial ability. For CNS
vascular permeability, mice with FITC scores <500 were
placed in the low F2 group while mice with FITC scores
>500 were placed in the high F2 group for analysis. Since
data were scored in a binomial fashion, we used a chi-
square test, which is a nonparametric approach, to de-
termine significance. We identified the critical interval
for significant QTL and performed a search using www.
informatics.jax.org to compile a list of candidate genes.
These genes were then prioritized based on their known
or presumed biological function. We then used the
Mouse Phenome Database (www.phenome.jax.org) to
determine the number of SNPs in these genes of interest
that are different between the B6 and 129S1 mouse
strains as well as the location of these SNPs. These genes
will set the stage for future experiments on gene expres-
sion and strain differences that may be related to the
mechanism of CD8 T cell-initiated BBB disruption.Availability of supporting data
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